« Back to Record
Citation APA

Eggermont, A. A., Rutkowski, P., Dutriaux, C., Hofman-Wellenhof, R., Dziewulski, P., Marples, M., Grange, F., Lok, C., Pennachioli, E., Robert, C., van Akkooi, A. A., Bastholt, L., Minisini, A. M., Marshall, E., Sales, F., Grob, J. J., Bechter, O., Schadendorf, D., Marreaud, S., Kicinski, M., Suciu, S., & Testori, A. (2020). Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial. European journal of cancer, 133, 94-103. doi:10.1016/j.ejca.2020.04.015


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/309066

Eggermont, A. A., Rutkowski, P., Dutriaux, C., Hofman-Wellenhof, R., Dziewulski, P., Marples, M., Grange, F., Lok, C., Pennachioli, E., Robert, C., van Akkooi, A. A., Bastholt, L., Minisini, A. M., Marshall, E., Sales, F., Grob, J. J., Bechter, O., Schadendorf, D., Marreaud, S., Kicinski, M., Suciu, S., & Testori, A. (2020). Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial. European journal of cancer, 133, 94-103. doi:10.1016/j.ejca.2020.04.015